ResMed | RMD - Interest Expense On Debt


ResMed reported $8.79M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Ansell USD 20.6M 300K Dec/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Cochlear AUD 6.3M 3.65M Dec/2025
Cooper Companies USD 20.9M 1.5M Mar/2026
CSL USD 215M 111M Dec/2025
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Fisher Paykel Healthcare NZD 4.8M 700K Jun/2026
Globus Medical USD 5.44B 5.44B Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
Idexx Laboratories USD 10.18M 2.44M Jun/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
Medtronic USD 176M 5M Mar/2026
Philips EUR 83M 26M Mar/2026
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Steris USD 15.1M 200K Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026